“Recently Approved Recombinant Factor VIII (rFVIII) for the Replacement Treatment in Patients With Hemophilia A in Italy”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 18, no. 1, Oct. 2017, https://doi.org/10.7175/fe.v18i1.1321.